anti-abuse drug delivery

Red stock market line indicating recession and superimposed dollar bill
Pharma

Vallon's abuse-resistant Adderall fails clinical trial

ADAIR diid no better than the reference formulation of the stimulant dextroamphetamine on a measure of abuse liability, causing the trial to fail.
Nick Paul Taylor Mar 22, 2022 7:35am
OxyContin

Reworked OxyContin hasn't reduced opioid abuse, FDA panel says

Sep 21, 2020 12:58pm
FDA

Endo's Opana faces FDA action after panel's vote

Mar 15, 2017 9:40am
Crushed tablet

Grunenthal insists crush-proof tablet works after Endo pulls Opana sNDA

Aug 30, 2016 9:28am